USANA Health Sciences(US:USNA) Businesswire·2026-01-12 11:15Core Viewpoint - USANA Health Sciences, Inc. has announced preliminary fiscal year 2025 net sales of approximately $925 million, exceeding previous guidance, and provided initial net sales guidance for fiscal year 2026 in the range of $925 million to $1.0 billion [2][3]. Fiscal Year 2025 Net Sales Results - The company anticipates consolidated net sales for fiscal year 2025 to be around $925 million, which is an increase from the previously issued guidance of approximately $920 million [2]. Initial Fiscal Year 2026 Net Sales Outlook - The initial net sales outlook for fiscal year 2026 is projected to be between $925 million and $1.0 billion, driven by significant growth in the Rise Wellness segment, which includes Rise Bar and Protein Pop [3]. - Rise Wellness is expected to achieve breakeven operating margins in fiscal 2026 as the company invests in strategic initiatives for future growth [3]. Investments in Growth - The company is making substantial investments in inventory, capital expenditures, and working capital for both Rise Wellness and Hiya to support their early growth stages [4]. Participation in ICR Conference - USANA will participate in the 28th Annual ICR Conference on January 12-13, 2026, where key executives will present the company's strategy and sales outlook [5]. Fourth Quarter and Fiscal Year 2025 Earnings Release - Preliminary financial results and the initial fiscal 2026 sales outlook will be updated during the earnings release scheduled for February 17, 2026, followed by a conference call on February 18, 2026 [6]. Segment-Specific Net Sales Projections for Fiscal Year 2026 - Projected net sales for fiscal year 2026 include: - Core nutritional business: $720 to $765 million (down from approximately $777 million in fiscal 2025) - Hiya: $140 to $155 million (up from approximately $132 million in fiscal 2025) - Rise Wellness: $65 to $80 million (up from approximately $16 million in fiscal 2025) [8].